Methylprednisolone and the adult respiratory distress syndrome
dc.contributor.author | Du Toit, H. J. | |
dc.contributor.author | Erasmus, F. R. | |
dc.contributor.author | MacFarlane, C. M. | |
dc.contributor.author | Taljaard, J. J. F. | |
dc.contributor.author | King, J. B. | |
dc.contributor.author | De Klerk, A. J. | |
dc.contributor.author | Elk, E. | |
dc.date.accessioned | 2011-03-18T14:59:45Z | |
dc.date.available | 2011-03-18T14:59:45Z | |
dc.date.issued | 1984-06 | |
dc.description | The original publication is available at http://archive.samj.org.za/ | en_ZA |
dc.description.abstract | Total hip replacement was carried out on 22 patients under general anaesthesia. Of these, 10 were pretreated with methylprednisolone (30 mg/kg); 1 of these developed the adult respiratory distress syndrome (ARDS) and had high levels of thromboxane B2 (TXB2) 5 minutes after fixation of the femoral prosthesis and at the end of the operation. The other 12 patients served as controls; 5 of them developed ARDS and had statistically significant higher TXB2 levels than the other 7 control patients who remained well. All patients who did not develop ARDS had low TXB2 levels. TXB2 and β-thromboglobulin levels followed the same trend and there was good correlation (r = 0.6806; P < 0.01) at the end of the operation in the control group patients who developed ARDS. There was no statistical difference in 6-keto-PGF(1α) levels between the patients who developed ARDS and those in the control group who remained well. Steroids reduce arachidonic acid metabolism by inhibiting the release of substrate for cyclo-oxygenase and lipoxygenase activity. Patients prone to ARDS thus benefit from methylprednisolone administration. | en_ZA |
dc.description.version | Publishers' version | |
dc.format.extent | p. 1049-1053 : ill. | |
dc.identifier.citation | Du Toit, H.J. et al. 1984. Methylprednisolone and the adult respiratory distress syndrome. SA mediese tydskrif, 65(26):1049-1053 | |
dc.identifier.issn | 2078-5135 (online) | |
dc.identifier.issn | 0256-9574 (print) | |
dc.identifier.uri | http://hdl.handle.net/10019.1/8031 | |
dc.publisher | Open access journal | en_ZA |
dc.publisher | HMPG | |
dc.rights.holder | Authors retain copyright | en_ZA |
dc.subject | Methylprednisolone | en_ZA |
dc.subject | Total hip replacement | en_ZA |
dc.subject | Anesthesia | en_ZA |
dc.subject | Respiratory distress syndrome | en_ZA |
dc.title | Methylprednisolone and the adult respiratory distress syndrome | en_ZA |
dc.type | Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- dutoit_methylprednisolone_1984.pdf
- Size:
- 3.01 MB
- Format:
- Adobe Portable Document Format
- Description:
- Publishers' Version